Neumora Therapeutics Inc (NMRA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -110.558 | -30.602 | -51.153 |
Return on Equity (%) | 145.939 | 33.91 | -2122.964 |
Return on Invested Capital (%) | -120.168 | -35.559 | -61.016 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 0.407 | 0.775 | 1.143 |
Earnings Per Share | -0.239 | -0.256 | -0.575 |
Cash Per Share | 0.412 | 0.471 | 0.912 |
Working Capital Per Share | 0.395 | 0.712 | 1.105 |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | -0.239 | -0.256 | -0.574 |
EBITDA Per Share | -0.239 | -0.256 | -0.574 |
Free Cash Flow Per Share | -0.238 | -0.256 | -0.576 |
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Actions en circulation | 250,96M | 255,88M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Capitalisation boursière | 318,28M |
Ratio cours/bénéfice | -1,49 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,94 |
Ratio prix/valeur comptable | 0,75 |
Rendement de dividende | - |
Actions en circulation | 161,56M |
Volume moyen (1 semaine) | 11,7M |
Volume moyen (1 mois) | 3,3M |
Variation sur 52 semaines | -87,61% |
Plus haut sur 52 semaines | 21,00 |
Plus bas sur 52 semaines | 1,83 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales